EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Cortical excitability stratifies neurochemical profiles in amyotrophic lateral sclerosis

Sicong Tu iD, Colin J Mahoney, William Huynh, Steve Vucic, Matthew C Kiernan

Brain Communications · 2026-07-01 · 8 (4)

DOI: 10.1093/braincomms/fcag292 ↗

At a glance

Journal article in Brain Communications, published online on 2026-07-28. Written by Sicong Tu and 4 co-authors. Institution: Brain and Mind Centre, The University of Sydney, Sydney, NSW 2050, Australia. 57 references. The full text is freely available (open access, CC BY 4.0). Funded by: Lenity Australia, MND Research Institute of Australia, FightMND.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Transsynaptic deficits arising from an imbalance in excitatory/inhibitory inter-neuronal circuitry have been extensively shown to underlie the phenomena of altered cortical motor excitability in patients with amyotrophic lateral sclerosis (ALS), with glutamate-induced excitotoxicity believed to represent a primary mechanism of ALS pathogenesis. In vivo evidence of glutamate abnormality in ALS patients, however, remains inconsistent, likely reflecting heterogeneity in the severity of underlying cortical dysfunction. The current study assessed the utility of short interval intracortical inhibition (SICI), a validated marker of upper motor neuron (UMN) dysfunction in ALS, to stratify cortical motor metabolite abnormalities, as determined by proton magnetic resonance spectroscopy (1H-MRS). Serial 1H-MRS data were acquired over 2.5 years for two ALS participants with contrasting profiles of progressive motor dysfunction as a pilot study. Longitudinal monitoring of these participants demonstrated stable cortical motor metabolite concentrations in the participant with lower motor predominant disease presentation but progressive changes in glutamate–glutamine (Glx) and N-acetylaspartate (NAA) concentrations in the participant with a classical ALS presentation. Fifty-four participants (34 ALS; 20 control) were prospectively recruited for a formal study. All patients underwent threshold-tracking transcranial magnetic stimulation) and were classified as having high (>5.5%; H-SICI) or low (≤5.5%; L-SICI) cortical motor inhibition. Matching 3T single-voxel 1H-MRS data were acquired from the hand region of the motor cortex for all participants at baseline, with a subset of patients (n = 10) longitudinally assessed at 6 months. Dissociable patterns of pathological change in NAA and Glx/NAA metabolites were observed at baseline and longitudinally in ALS. At baseline, L-SICI ALS participants with increased cortical motor excitability demonstrated a significant bilateral reduction in NAA and elevated Glx/NAA metabolite concentrations (P-values < 0.03), contrasting to H-SICI ALS participants, where the neurochemical concentration was preserved. At follow-up, H-SICI patients demonstrated a trend towards elevated Glx and Glx/NAA in the left motor cortex (P-values ≤ 0.06). In contrast, L-SICI patients demonstrated stable concentrations of Glx but further reductions in NAA ratio (P = 0.04). Cortical excitability and brain neurochemical profile abnormalities reflect evolving states of UMN dysfunction in ALS. Elevated Glx/NAA metabolite concentration underlies greater cortical motor dysfunction in ALS. Longitudinal 1H-MRS holds potential prognostic utility for clinical monitoring of ALS disease trajectory.

Subjects

Author keywords

amyotrophic lateral sclerosiscortical excitabilitymagnetic resonance spectroscopymotor neuron diseasethreshold-tracking TMS

Authors and institutions

  • Brain and Mind Centre, The University of Sydney, Sydney, NSW 2050, Australia.
  • Sydney Medical School, Faculty of Medicine & Health, The University of Sydney, Sydney, NSW 2006, Australia.
  • Neuroscience Research Australia, Scientia Professor of Neuroscience, University of NSW, Sydney, NSW 2031, Australia.
  • Department of Neurology, Liverpool Hospital, South-Western Sydney Local Health District, Sydney, NSW 2170, Australia.
  • Brain and Nerve Research Centre, Concord Clinical School, The University of Sydney, Sydney, NSW 2139, Australia.

ORCID profiles: Sicong Tu

Funding

  • Lenity Australia
  • MND Research Institute of Australia
  • FightMND
  • National Health and Medical Research Council
  • Program
  • Partnership Project
  • Practitioner Fellowship

Cite

APA

Tu, S., Mahoney, C. J., Huynh, W., Vucic, S., & Kiernan, M. C. (2026). Cortical excitability stratifies neurochemical profiles in amyotrophic lateral sclerosis. Brain Communications, 8(4). https://doi.org/10.1093/braincomms/fcag292

Vancouver

Tu S, Mahoney CJ, Huynh W, Vucic S, Kiernan MC. Cortical excitability stratifies neurochemical profiles in amyotrophic lateral sclerosis. Brain Communications. 2026;8(4). doi:10.1093/braincomms/fcag292

BibTeX
@article{Tu2026,
  author = {Tu, Sicong and Mahoney, Colin J and Huynh, William and Vucic, Steve and Kiernan, Matthew C},
  title = {Cortical excitability stratifies neurochemical profiles in amyotrophic lateral sclerosis},
  journal = {Brain Communications},
  year = {2026},
  volume = {8},
  number = {4},
  doi = {10.1093/braincomms/fcag292}
}
Start for free →